For people who constantly think about what they are going to eat meal to meal, their food noise goes down significantly’ ...

GLP-1 weight loss patches are everywhere but do they actually work as these trendy patches promise Ozempic-like results ...

NVO is expanding into rare blood disorders like hemophilia to ease reliance on GLP-1 drugs Ozempic and Wegovy.

MariTide, a new drug from Amgen, helped some people with obesity lose up to 20% of their body weight. In a phase 2 trial, a new GLP-1 drug helped people lose up to 20% of their body weight over a year ...

Wall Street's smartest money has quietly amassed over $150 million in bullish positions, with Goldman Sachs eliminating all ...

As weight-loss injections like Mounjaro and Wegovy soar in popularity across the UK, jewellers say they’re seeing an unexpected side effect: wedding and engagement rings no longer fit, and in they are ...

But it’s taking neither seriously. Despite the fact that more than 64% of people in the UK are either overweight or obese our ...

The 10-year plan for the health service says there is a need to expand access to weight-loss services and treatments and ...

SIR Keir Starmer has vowed to fix the “broken NHS” by dragging it “from bricks to clicks” in a technological revolution. The ...

A nurse has warned about a common Mounjaro ‘mistake’ that can increase people’s risk of deadly organ damage.

Ozempic could help with his as a study by Goldman Sachs found that the mass-adoption of GLP-1 series drugs could allow for ...

VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.